Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials.
Arkady T Manning-BennettJulie CervesiPierre-Alain BandinelliMichael J SorichAshley M HopkinsPublished in: Biomedicines (2023)
Antibiotic use within a ±6-week window was significantly associated with worse PFS and OS.